Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Heffernan

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
Combining traditional systemic and biologic therapies for psoriasisMichael P Heffernan
Archives of Dermatology|January 18, 2006
The era of cooperationMichael P Heffernan
Dermatologic Clinics|June 1, 2010
Innovative uses of rituximab in dermatologyDavid R Carr, Michael P Heffernan
Facial Plastic Surgery Clinics of North America|April 6, 2004
Facial signs of systemic diseaseMichael M Nelson, Michael P Heffernan
Archives of Dermatology|January 18, 2006
Adalimumab for treatment of cutaneous sarcoidosisMichael P Heffernan, David I Smith
Archives of Dermatology|July 20, 2005
Recalcitrant cutaneous sarcoidosis responding to infliximabMichael P Heffernan, Milan J Anadkat
Dermatology Nursing|July 9, 2002
Synopsis of antinuclear antibodies in dermatologyMichael M Nelson, Michael P Heffernan
Archives of Dermatology|October 18, 2006
Successful treatment of mucous membrane pemphigoid with infliximabMichael P Heffernan, Danette D Bentley
Dermatologic Therapy|November 1, 2007
Off-label uses of rituximab in dermatologyDavid R Carr, Michael P Heffernan
Journal of the American Academy of Dermatology|January 23, 2008
Vitiligo after the resolution of psoriatic plaques during treatment with adalimumabDavid I Smith, Michael P Heffernan
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
Combining traditional systemic and biologic therapies for psoriasisMichael P Heffernan
Archives of Dermatology|January 18, 2006
The era of cooperationMichael P Heffernan
Dermatologic Clinics|June 1, 2010
Innovative uses of rituximab in dermatologyDavid R Carr, Michael P Heffernan
Facial Plastic Surgery Clinics of North America|April 6, 2004
Facial signs of systemic diseaseMichael M Nelson, Michael P Heffernan
Archives of Dermatology|January 18, 2006
Adalimumab for treatment of cutaneous sarcoidosisMichael P Heffernan, David I Smith
Archives of Dermatology|July 20, 2005
Recalcitrant cutaneous sarcoidosis responding to infliximabMichael P Heffernan, Milan J Anadkat
Dermatology Nursing|July 9, 2002
Synopsis of antinuclear antibodies in dermatologyMichael M Nelson, Michael P Heffernan
Archives of Dermatology|October 18, 2006
Successful treatment of mucous membrane pemphigoid with infliximabMichael P Heffernan, Danette D Bentley
Dermatologic Therapy|November 1, 2007
Off-label uses of rituximab in dermatologyDavid R Carr, Michael P Heffernan
Journal of the American Academy of Dermatology|January 23, 2008
Vitiligo after the resolution of psoriatic plaques during treatment with adalimumabDavid I Smith, Michael P Heffernan
Pageof 4